Loading…

Browse All Grants

201,169 grants found

Filters
Reset

Showing 198,161198,180 of 201,169 grants

Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$3.61M
USD
Completed SBIR-STTR RPGS
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Aeon Respire, Inc United States 2021 – 2023

Project Summary The business objective of Aeon Respire, and the purpose of this SBIR Project, is to execute key steps towards repurposing niclosamide as a new asthma treatment. The...

$11.93M
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$3.61M
USD
Completed SBIR-STTR RPGS
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Aeon Respire, Inc United States 2021 – 2024

Project Summary The business objective of Aeon Respire, and the purpose of this SBIR Project, is to execute key steps towards repurposing niclosamide as a new asthma treatment. The...

$9.93M
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies.
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

Summary - A fundamental theme in personalized cancer medicine is to identify specific subgroups of patients, based on molecular biomarkers and/or tumor signatures, which will subse...

$507.4K
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$1.45M
USD
Completed NON-SBIR/STTR RPGS
A K63-Ubiquitination Dependent Necroptosis Signaling Network in the Heart
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Washington United States 2021 – 2025

Project Summary/Abstract Loss of cardiomyocytes by apoptosis and/or necrosis is a hallmark of cardiac ischemic injury, pathological remodeling, and end-stage heart failure.Although...

$3.89M
USD
Completed NON-SBIR/STTR RPGS
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Iowa United States 2021 – 2025

Heart failure (HF) is the most common reason for hospitalization and death among those older than 65-years, and statistic is projected to grow as our population ages. The socioecon...

$5.9M
USD
Completed NON-SBIR/STTR RPGS
A microbiome-dependent bile acid metabolite improves type 2 diabetes.
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Brigham and Women'S Hospital United States 2021 – 2025

Project Summary/Abstract The molecular mechanisms that explain the potent anti-diabetic effects of bariatric surgery remain elusive.The rapid nature of type 2 diabetes mellitus (T2...

$7M
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.45M
USD
Completed NON-SBIR/STTR RPGS
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Johns Hopkins University United States 2021 – 2024

Excess glucocorticoids contribute to the development of diabetes and metabolic syndrome, which includes: obesity, hyperglycemia, hypercholesterolemia, insulin resistance, and liver...

$5.32M
USD
Completed OTHER RESEARCH-RELATED
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT This project takes a unique dynamic view of signaling by receptor tyrosine kinases (RTKs), testing the hypothesis that signaling specificity is kinetically...

$977.6K
USD
Completed NON-SBIR/STTR RPGS
Novel dual-targeted inhibitors of EGFR and aurora kinase for lung cancer
NATIONAL CANCER INSTITUTE Ferris State University United States 2021 – 2023

PROJECT SUMMARY Small molecule EGFR inhibitors constitute the recommended therapy for EGFR-positive non-small cell lung cancer (NSCLC).Resistance was first reported to EGFR inhibit...

$3.78M
USD
Completed NON-SBIR/STTR RPGS
Social Networks of Diffusion and Adoption: Investigating the Network Effects on implementation of evidence-based interventions for early intervention providers of children
NATIONAL INSTITUTE OF MENTAL HEALTH Drexel University United States 2021 – 2022

Early interventions for preschoolers with Autism Spectrum Disorder (ASD) can result in substantial improvements across cognitive and communication outcomes.1 However, treatment res...

$2.43M
USD
Completed OTHER RESEARCH-RELATED
Supporting Personalized Decision Making for Breast Cancer Screening among Older Women
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT In the United States, approximately half of women 75 and older undergo screening mammography.Despite widespread use, the benefits of mammography in this ag...

$2.57M
USD
Completed NON-SBIR/STTR RPGS
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES University of Massachusetts Med Sch Worc... United States 2021 – 2024

MASSI/ BOSCO ?ABSTRACT Profilin-1 (PFN1) is a 15kDa actin-binding protein that plays a critical role in regulating cytoskeletal dynamics. In order to promote actin polymerization i...

$5.08M
USD
Completed NON-SBIR/STTR RPGS
Longitudinal Antibody Profiles Correlated with Protection from Malaria in Malawi
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Boston University Medical Campus United States 2021 – 2022

PROJECT SUMMARY Malaria continues to be responsible for substantial childhood mortality in Africa despite current control efforts.Developing an effective vaccine for malaria elimin...

$2.76M
USD
Completed NON-SBIR/STTR RPGS
Intratumor co-delivery of DNA and RNA to relieve cancer pain
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... New York University United States 2021 – 2025

Oral cancer causes more prevalent and severe pain than any other cancer.Oral cancer patients suffer from severe, chronic, mechanically-induced pain; talking and eating are profound...

$5.84M
USD
Completed OTHER RESEARCH-RELATED
Advancing Drug Development in AL Amyloidosis: Capitalizing Natural History and Assessing Endpoints
NATIONAL INSTITUTE ON AGING Amyloidosis Research Consortium, Inc United States 2021 – 2021

Project Summary Amyloidosis Research Consortium (ARC), a 501(c)(3) nonprofit organization focused on accelerating the development, approval, and access to new and innovative treatm...

$243.9K
USD